Enhanced Antidepressant Activity of Nanostructured Lipid Carriers Containing Levosulpiride in Behavioral Despair Tests in Mice

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2023 Sep 28

PMID 37765028

Authors

Sadia Tabassam Arif

Muhammad Ayub Khan

Shahiq Uz Zaman

Hafiz Shoaib Sarwar

Abida Raza

Muhammad Sarfraz

Yousef A Bin Jardan

Muhammad Umair Amin

Muhammad Farhan Sohail

Affiliations

Soon will be listed here.

Abstract

The potential of levosulpiride-loaded nanostructured lipid carriers (LSP-NLCs) for enhanced antidepressant and anxiolytic effects was evaluated in the current study. A forced swim test (FST) and tail suspension test (TST) were carried out to determine the antidepressant effect whereas anxiolytic activity was investigated using light-dark box and open field tests. Behavioral changes were evaluated in lipopolysaccharide-induced depressed animals. The access of LSP to the brain to produce therapeutic effects was estimated qualitatively by using fluorescently labeled LSP-NLCs. The distribution of LSP-NLCs was analyzed using ex vivo imaging of major organs after oral and intraperitoneal administration. Acute toxicity studies were carried out to assess the safety of LSP-NLCs in vivo. An improved antidepressant effect of LSP-NLCs on LPS-induced depression showed an increase in swimming time (237 ± 51 s) and struggling time (226 ± 15 s) with a reduction in floating (123 ± 51 s) and immobility time (134 ± 15 s) in FST and TST. The anxiolytic activity in the light-dark box and open field tests exhibited superiority over LSP dispersion. Near-infrared images of fluorescently labeled LSP-NLCs demonstrated the presence of coumarin dye in the brain after 1 h of administration. An acute toxicity study revealed no significant changes in organ-to-body weight ratio, serum biochemistry or tissue histology of major organs. It can be concluded that nanostructured lipid carriers can efficiently deliver LSP to the brain for improved therapeutic efficacy.

References

Sarwar H, Sohail M, Saljoughian N, Ur Rehman A, Akhtar S, Nadhman A . Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis. Artif Cells Nanomed Biotechnol. 2018; 46(sup1):521-531. DOI: 10.1080/21691401.2018.1430699. View

Cunha S, Almeida H, Amaral M, Sousa Lobo J, Silva A . Intranasal lipid nanoparticles for the treatment of neurodegenerative diseases. Curr Pharm Des. 2017; . DOI: 10.2174/1381612824666171128105305. View

Wang K, Cheng F, Pan X, Zhou T, Liu X, Zheng Z . Investigation of the transport and absorption of Angelica sinensis polysaccharide through gastrointestinal tract both in vitro and in vivo. Drug Deliv. 2017; 24(1):1360-1371. PMC: 8240978. DOI: 10.1080/10717544.2017.1375576. View

Jangra A, Kwatra M, Singh T, Pant R, Kushwah P, Sharma Y . Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice. Inflammation. 2016; 39(3):1025-38. DOI: 10.1007/s10753-016-0332-4. View

Salunkhe S, Bhatia N, Bhatia M . Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain. Drug Deliv. 2014; 23(4):1306-16. DOI: 10.3109/10717544.2014.943337. View

Sabzichi M, Mohammadian J, Mohammadi M, Jahanfar F, Movassagh Pour A, Hamishehkar H . Vitamin D-Loaded Nanostructured Lipid Carrier (NLC): A New Strategy for Enhancing Efficacy of Doxorubicin in Breast Cancer Treatment. Nutr Cancer. 2017; 69(6):840-848. DOI: 10.1080/01635581.2017.1339820. View

Yousaf R, Khan M, Akhtar M, Madni A, Sohail M, Saleem A . Development and evaluation of chitosan and glyceryl monostearate based matrix lipid polymer hybrid nanoparticles (LPHNPs) for oral delivery of itraconazole. Heliyon. 2023; 9(3):e14281. PMC: 10010992. DOI: 10.1016/j.heliyon.2023.e14281. View

Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C . Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007; 59(6):454-77. DOI: 10.1016/j.addr.2007.04.011. View

Khan M, Ansari M, Arif S, Raza A, Choi H, Lim C . Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability. Drug Deliv. 2021; 28(1):2510-2524. PMC: 8635601. DOI: 10.1080/10717544.2021.2008051. View

10.

Jaiswal P, Gidwani B, Vyas A . Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol. 2014; 44(1):27-40. DOI: 10.3109/21691401.2014.909822. View

11.

Saleem U, Ahmad B, Ahmad M, Erum A, Hussain K, Bukhari N . Is folklore use of Euphorbia helioscopia devoid of toxic effects?. Drug Chem Toxicol. 2015; 39(2):233-7. DOI: 10.3109/01480545.2015.1092040. View

12.

Alam M, Najmi A, Ahmad I, Ahmad F, Akhtar M, Imam S . Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in-vitro assessment and bioactivity detail in rats. Artif Cells Nanomed Biotechnol. 2018; 46(sup2):46-57. DOI: 10.1080/21691401.2018.1451873. View

13.

Vitorino C, Silva S, Gouveia F, Bicker J, Falcao A, Fortuna A . QbD-driven development of intranasal lipid nanoparticles for depression treatment. Eur J Pharm Biopharm. 2020; 153:106-120. DOI: 10.1016/j.ejpb.2020.04.011. View

14.

Singh T, Sinha N, Singh A . Biochemical and histopathological effects on liver due to acute oral toxicity of aqueous leaf extract of Ecliptaalba on female Swiss albino mice. Indian J Pharmacol. 2013; 45(1):61-5. PMC: 3608297. DOI: 10.4103/0253-7613.106437. View

15.

Sohail M, Sarwar H, Javed I, Nadhman A, Hussain S, Saeed H . Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes. Toxicol Res (Camb). 2018; 6(6):814-821. PMC: 6061422. DOI: 10.1039/c7tx00146k. View

16.

Alam M, Baboota S, Ahuja A, Ali M, Ali J, Sahni J . Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug. Int J Pharm. 2014; 470(1-2):99-106. DOI: 10.1016/j.ijpharm.2014.05.004. View

17.

Pina Costa C, Barreiro S, Moreira J, Silva R, Almeida H, Sousa Lobo J . In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals (Basel). 2021; 14(8). PMC: 8400558. DOI: 10.3390/ph14080711. View

18.

Cho H, Lee Y . Improvement and validation of a liquid chromatographic method for the determination of levosulpiride in human serum and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 796(2):243-51. DOI: 10.1016/j.jchromb.2003.07.009. View

19.

Pandey Y, Kumar S, Gupta B, Ali J, Baboota S . Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Nanotechnology. 2015; 27(2):025102. DOI: 10.1088/0957-4484/27/2/025102. View

20.

Ford C . The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience. 2014; 282:13-22. PMC: 4108583. DOI: 10.1016/j.neuroscience.2014.01.025. View